UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients

Cancer science, 2018-06, Vol.109 (6), p.2046-2055

2018

Link zum Volltext

Verfügbarkeit prüfen

Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

Journal for immunotherapy of cancer, 2021-09, Vol.9 (9), p.e003521

2021

Link zum Volltext

Verfügbarkeit prüfen

Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma

British journal of cancer, 2020-02, Vol.122 (3), p.413-420

2020

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma

Oncotarget, 2016-07, Vol.7 (30), p.47252-47264

2016

Link zum Volltext

Verfügbarkeit prüfen

Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma

Gastrointestinal endoscopy, 2016-06, Vol.83 (6), p.1130-1139.e3

2016

Link zum Volltext

Verfügbarkeit prüfen

Review of early endoscopic findings in patients with local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma

Esophagus : official journal of the Japan Esophageal Society, 2020-10, Vol.17 (4), p.433-439

2020

Link zum Volltext

Verfügbarkeit prüfen

927 Wilms tumor reveals DNA repair gene hyper-expression is linked to lack of immune infiltration

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A972-A972

2021

Link zum Volltext

Verfügbarkeit prüfen

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy

Journal for immunotherapy of cancer, 2019-03, Vol.7 (1), p.66-66, Article 66

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for febrile neutropenia in neoadjuvant docetaxel, cisplatin, and 5-fluorouracil chemotherapy for esophageal cancer

Supportive care in cancer, 2020-04, Vol.28 (4), p.1849-1854

2020

Link zum Volltext

Verfügbarkeit prüfen

Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration

Journal for immunotherapy of cancer, 2022-06, Vol.10 (6), p.e004797

2022

Link zum Volltext

Verfügbarkeit prüfen

328 Batf3 dendritic cells and 4–1BB/4–1BB ligand axis are required at the effector phase within the tumor microenvironment for anti-PD-L1 efficacy

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A354-A354

2021

Link zum Volltext

Verfügbarkeit prüfen

Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?

Digestive endoscopy, 2018-05, Vol.30 (3), p.338-346

2018

Link zum Volltext

Verfügbarkeit prüfen

Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma

BMC cancer, 2017-01, Vol.17 (1), p.36-36, Article 36

2017

Link zum Volltext

Verfügbarkeit prüfen

Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer

Radiation oncology (London, England), 2016-02, Vol.11 (31), p.31, Article 31

2016

Link zum Volltext

Verfügbarkeit prüfen

Cancer types applicable to efficacy assessment using real-world data analyzed from PMDA-approved data

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19272-e19272

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy evaluation of anticancer agents in single-arm clinical trials: analysis of review reports from Pharmaceuticals and Medical Devices Agency

Acta oncologica, 2021-02, Vol.60 (2), p.143-148

2021

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

Clinical cancer research, 2022-06, Vol.28 (12), p.2547-2554

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of enhanced visibility in evaluating polyposis syndromes using a newly developed contrast image capsule endoscope

Gut and Liver, 2012, 6(2), , pp.218-222

2012

Link zum Volltext

Verfügbarkeit prüfen

The Tumor Microenvironment of Bladder Cancer

Tumor Microenvironments in Organs, 2020, Vol.1296, p.275-290

Birbrair, Alexander

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS18-01: Glucocorticoid receptor expression in early-stage triple-negative breast cancer is associated with a high level of tumor immune cell infiltrates

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS18-01-PS18-01

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular Subtypes of Gastric Cancer

Gan to kagaku ryoho, 2016-03, Vol.43 (3), p.281

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery

Journal of surgical oncology, 2016-03, Vol.113 (4), p.390-396

2016

Link zum Volltext

Verfügbarkeit prüfen

Coformulated quavonlimab and pembrolizumab (pembro) in combination with lenvatinib (lenva) as first-line (1L) therapy for patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 2 KEYSTEP-004 study

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.484-484

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2813: Clinical impact of immune microenvironment according to intratumoral locations of esophageal squamous cell carcinoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2813-2813

2019

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma (aHCC): 3-year follow-up of the phase 2 KEYNOTE-224 study

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (16_suppl), p.4109-4109

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(19)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Oncology
(15)
Male
(14)
Middle Aged
(14)
Female
(12)
Esophageal Cancer
(11)
Adult
(9)
Aged
(9)
Esophageal Neoplasms - Pathology
(8)
Esophageal Squamous Cell Carcinoma
(8)
Immunotherapy
(7)
Metastasis
(7)
Tumors
(7)
Cancer
(6)
Carcinoma, Squamous Cell - Pathology
(6)
Chemotherapy
(6)
Gastroenterology And Hepatology
(6)
Lymphocytes
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients

Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma

Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma

Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma

Review of early endoscopic findings in patients with local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma

927 Wilms tumor reveals DNA repair gene hyper-expression is linked to lack of immune infiltration

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy

Risk factors for febrile neutropenia in neoadjuvant docetaxel, cisplatin, and 5-fluorouracil chemotherapy for esophageal cancer

Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration

328 Batf3 dendritic cells and 4–1BB/4–1BB ligand axis are required at the effector phase within the tumor microenvironment for anti-PD-L1 efficacy

Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?

Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma

Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer

Cancer types applicable to efficacy assessment using real-world data analyzed from PMDA-approved data

Efficacy evaluation of anticancer agents in single-arm clinical trials: analysis of review reports from Pharmaceuticals and Medical Devices Agency

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

Role of enhanced visibility in evaluating polyposis syndromes using a newly developed contrast image capsule endoscope

The Tumor Microenvironment of Bladder Cancer

Abstract PS18-01: Glucocorticoid receptor expression in early-stage triple-negative breast cancer is associated with a high level of tumor immune cell infiltrates

Molecular Subtypes of Gastric Cancer

Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery

Coformulated quavonlimab and pembrolizumab (pembro) in combination with lenvatinib (lenva) as first-line (1L) therapy for patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 2 KEYSTEP-004 study

Abstract 2813: Clinical impact of immune microenvironment according to intratumoral locations of esophageal squamous cell carcinoma

Pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma (aHCC): 3-year follow-up of the phase 2 KEYNOTE-224 study

Suchergebnisse filtern